A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial
Document Type
Journal Article
Publication Date
2001
Journal
American Heart Journal
Volume
142
Issue
2
Inclusive Pages
244-247
Keywords
Medicine
APA Citation
Ross, A., Gao, R., Coyne, K., Chen, J., & Yao, K. (2001). A randomized trial confirming the efficacy of reduced dose recombinant tissue plasminogen activator in a Chinese myocardial infarction population and demonstrating superiority to usual dose urokinase: the TUCC trial. American Heart Journal, 142 (2). Retrieved from https://hsrc.himmelfarb.gwu.edu/smhs_medicine_facpubs/1831
COinS